imaGenes will complement its offerings with BioTrove’s OpenArray® platform, a nanoliter real-time qPCR system that allows for about 9,000 assays simultaneously. imaGenes is BioTrove’s first OpenArray service provider for real-time qPCR analysis outside the U.S. “We chose imaGenes for their extensive experience in microarray and next-generation sequencing services,” says Derek Potter, BioTrove’s European director.
The high-throughput OpenArray platform delivers superior performance to comparative qPCR systems in a much easier to use format, according to the firms. The technology enables gene-expression profiling, miRNA-profiling analyses, and biomarker studies to be completed in days instead of weeks and at a much lower price, they add.
